Marshall Wace’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-87,743
| Closed | -$763K | – | 2685 |
|
|
2024
Q3 | $763K | Sell |
87,743
-341,849
| -80% | -$2.97M | ﹤0.01% | 1632 |
|
|
2024
Q2 | $2.94M | Buy |
+429,592
| New | +$2.94M | ﹤0.01% | 1093 |
|
|
2023
Q3 | – | Sell |
-15,149
| Closed | -$78.2K | – | 2183 |
|
|
2023
Q2 | $78.2K | Buy |
+15,149
| New | +$78.2K | ﹤0.01% | 1903 |
|
|
2022
Q4 | – | Sell |
-531,636
| Closed | -$2.21M | – | 2677 |
|
|
2022
Q3 | $2.21M | Buy |
+531,636
| New | +$2.21M | ﹤0.01% | 1510 |
|
|
2021
Q4 | – | Sell |
-89,335
| Closed | -$893K | – | 3460 |
|
|
2021
Q3 | $893K | Buy |
89,335
+76,221
| +581% | +$762K | ﹤0.01% | 1609 |
|
|
2021
Q2 | $186K | Buy |
+13,114
| New | +$186K | ﹤0.01% | 1951 |
|
|
2020
Q2 | – | Sell |
-32,533
| Closed | -$161K | – | 1809 |
|
|
2020
Q1 | $161K | Buy |
+32,533
| New | +$161K | ﹤0.01% | 1210 |
|